We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

AstraZeneca, Lilly to Study Immuno-Oncology Combination

News   Jun 01, 2015

 
AstraZeneca, Lilly to Study Immuno-Oncology Combination
 
 
Advertisement
 

RELATED ARTICLES

Study Indicates a Lack of Diversity in COVID-19 Clinical Trials

News

Despite disproportionately higher rates of COVID-19 infection, hospitalization and death among people of color, minority groups are significantly underrepresented in COVID-19 clinical trials, according to a new study.

READ MORE

Towards a Gene Therapy for Reversal of Aging-Associated Pulmonary Fibrosis

News

CNIO researchers pave the way for a future gene therapy to reverse pulmonary fibrosis associated with ageing.

READ MORE

Immune System Deviations Revealed in Severe COVID-19 Cases

News

A study has turned up immunological deviations and lapses that appear to spell the difference between severe and mild cases of COVID-19.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE